SBIR/STTR Research Award
Nitric oxide releasing ultra-slippery antibacterial surfaces for indwelling catheter applications
Award amount
$998,399Program and phase
SBIR · Phase IIAward year
2020Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Centers for Disease Control and Prevention
- Recipient company
- inNOveta Biomedical LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- HK8VNP32ANL7
- Solicitation number
- Not reported
- Topic code
- NCEZID-020-PHS2019
Research abstract
The objective of this potential project is to combine the long-term antibacterial efficacy of a silicone rubber, S-nitrosothiol based nitric oxide (NO) donor in combination with the liquid-infusion of silicone oil to provide an ultra-slippery interface to prevent bacterial and protein adhesion that can be used on indwelling urinary or intravascular catheters to prevent or significantly reduce biofilm formation by organisms known to cause healthcare-associated infections. The overall goal of Phase II is to provide data and specifications necessary to obtain initial 510(k) clearance and initiate clinical use of the NO generating SNAP catheter for reduced thrombosis and infection within one year of the completion of Phase II activities.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Ultra-low Fouling and Nitric Oxide Releasing Intravascular Catheters for Prevention of Thrombosis and Infection
- Nitric Oxide Releasing Ultra Slippery Antibacterial Surfaces for Indewelling Catheter Applications
Research funding history
3 SBIR/STTR records share this UEI (2019–2020). Reported award amounts total $1,298,247. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services